Mepolizumab in real-life treatment of severe eosinophilic asthma

Conclusion: Our experience confirms effect of mepolizumab treatment to improving of astma control and reducing of OCS use in real-life severe eosinophilic astma patients.

Source: European Respiratory Journal - October 28, 2020 Category: Respiratory Medicine Authors: Volakova, E., Zatloukal, J. Tags: Airway pharmacology and treatment Source Type: research